1007-3418
2005 Issue 10
..............page:737,748,758,775,插页
Development on HLA-restricted HBV-specific CTL epitopes
YU Yue-cheng;HOU Jin-lin
YU Yue-cheng;HOU Jin-lin
..............page:797-800
Clinical significance of the dysregulated expression of von Willebrand factor-cleaving protease in patients with primary hepatocarcinoma
GAO Wei-qiang;ZHOU Xiao-jun;BAI Xia;SU Jian;RUAN Chang-geng
GAO Wei-qiang;ZHOU Xiao-jun;BAI Xia;SU Jian;RUAN Chang-geng
..............page:795-796,800
An in vitro study on the mutant of HBV treated with interferon
WANG Wei-feng;ZHOU Xiao-dong
WANG Wei-feng;ZHOU Xiao-dong
..............page:793-794
The protective effect of MG132 on post-ischemia reperfusion injury of rat livers by activation of nuclear factor kappa B
JIN Shan;HAN Xi-chun;ZHANG Hong;HAN Ning
JIN Shan;HAN Xi-chun;ZHANG Hong;HAN Ning
..............page:791-792
Effects of serum with drug "KXEH" on activated hepatic stellate cells
LI Ping;HU Guo-ling;LIU Hong-bo;TAN De-ming
LI Ping;HU Guo-ling;LIU Hong-bo;TAN De-ming
..............page:788-790
Therapeutic effect of diammonium glycyrrhizinate lipid ligand on carbon-tetrarchloride induced fatty livers in rats
LU Lun-gen;XU Hong-jiang;WANG Ya-jing;XU Xi-kun;ZENG Min-de;MAO Yi-min;CAO Ai-ping
LU Lun-gen;XU Hong-jiang;WANG Ya-jing;XU Xi-kun;ZENG Min-de;MAO Yi-min;CAO Ai-ping
..............page:786-788
Approaches for interventional therapy of hepatoma
GUAN Yong-song;YANG Lin
GUAN Yong-song;YANG Lin
..............page:785
The principle of interventional therapy of hepatoma
ZHAO Jian-nong
ZHAO Jian-nong
..............page:784
Experimental study on the pathological effect of Helicobacter pylori on liver tissues
TIAN Xue-fei;FAN Xue-gong;FU Chun-yan;HUANG Yan;ZHU Cai
TIAN Xue-fei;FAN Xue-gong;FU Chun-yan;HUANG Yan;ZHU Cai
..............page:780-783
The expression and the significance of L-FABP and FATP4 in the development of nonalcoholic fatty liver disease in rats
FENG Ai-juan;CHEN Dong-feng
FENG Ai-juan;CHEN Dong-feng
..............page:776-779
Complete HBV DNA clone and sequence from serum samples of severe hepatitis B patients
WU Wei;LI Lan-juan;CHEN Yu;LI Jun;QIAN Xiang;CHENG Dong-qing
WU Wei;LI Lan-juan;CHEN Yu;LI Jun;QIAN Xiang;CHENG Dong-qing
..............page:734-737
Analysis of prognostic factors of and to establish a predictive model for patients with chronic severe hepatitis
ZHANG Nan;WANG Yu-ming;DENG Guo-hong;YI Dong
ZHANG Nan;WANG Yu-ming;DENG Guo-hong;YI Dong
..............page:730-733
Distribution and clinical significance of hepatitis B virus (HBV) genotypes and subtypes in HBV-infected patients
LI Ya-juan;ZHUANG Hui;LI Jie;DONG Qing-ming;CHEN Ya-jie;NIU Jun-qi;MA Wei-min;ZHAO Wei;ZHAO Bao-an;ZHONG Jin-qun
LI Ya-juan;ZHUANG Hui;LI Jie;DONG Qing-ming;CHEN Ya-jie;NIU Jun-qi;MA Wei-min;ZHAO Wei;ZHAO Bao-an;ZHONG Jin-qun
..............page:724-729
Interventional therapy for hepatocellular carcinoma
WANG Jian-hua
WANG Jian-hua
..............page:721-723
Use of autologous tumor vaccine in preventing recurrence of hepatocellular carcinoma
PENG Bao-gang;LIANG Li-jian;HE Qiang;ZHOU Fan;LAI Jia-ming;L(U) Ming-de;HUANG Jie-fu
PENG Bao-gang;LIANG Li-jian;HE Qiang;ZHOU Fan;LAI Jia-ming;L(U) Ming-de;HUANG Jie-fu
..............page:772-775
Inhibitory effect of cyclin D1 antisense cDNA on human hepatocarcinoma cell line HepG2
XIAO Zhen-yu;CHEN Xiao-ping;HUANG Zhi-yong
XIAO Zhen-yu;CHEN Xiao-ping;HUANG Zhi-yong
..............page:768-771
A cDNA microarray study of the differential expression of genes in signal transduction pathway during hepatocarcinogenesis in tree shrews
CHEN Yuan-neng;CAO Ji;SU Jian-jia;LI Yuan
CHEN Yuan-neng;CAO Ji;SU Jian-jia;LI Yuan
..............page:763-767
Inhibition of mutant-type p53 by a chimeric U6 maxizyme in hepatocellular carcinoma cell lines
KONG Xin-juan;LIN Ju-sheng;SONG Yu-hu;JIN You-xin
KONG Xin-juan;LIN Ju-sheng;SONG Yu-hu;JIN You-xin
..............page:759-762
A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol
LIU Rong;WANG Jian-hua;ZHOU Kang-rong;YAN Fu-hua;YAN Zhi-ping;SHEN Ji-zhang;TAN Yun-shan;CAI Yu
LIU Rong;WANG Jian-hua;ZHOU Kang-rong;YAN Fu-hua;YAN Zhi-ping;SHEN Ji-zhang;TAN Yun-shan;CAI Yu
..............page:754-758
A study of the down-regulation effect of hepatitis B virus pre-protein S2 on inducible nitric oxide synthase gene promoter
GUO Feng-jin;CHENG Jun;JI Dong;LIU Yan;ZHANG Li-Ying;SONG Fang-Zhou
GUO Feng-jin;CHENG Jun;JI Dong;LIU Yan;ZHANG Li-Ying;SONG Fang-Zhou
..............page:749-753
A study of 10-23 DNAzyme inhibiting the expression of hepatitis B virus genes
REN Na;WANG Feng;NIU Jun-qi
REN Na;WANG Feng;NIU Jun-qi
..............page:745-748
Interferon-α and ribavirin combination therapy for co-infection of hepatitis C virus and human immunodeficiency virus
ZHENG Yu-huang;HE Yan;YANG Xu;GONG Guo-zhong;ZHOU Hua-ying;ZHANG Chun-ying;ZOU Wen;HUANG Li;DING Pei-pei;LI Hui
ZHENG Yu-huang;HE Yan;YANG Xu;GONG Guo-zhong;ZHOU Hua-ying;ZHANG Chun-ying;ZOU Wen;HUANG Li;DING Pei-pei;LI Hui
..............page:741-744
Screening and cloning of hepatitis C virus non-structural protein 4A interacting protein gene in hepatocytes
LIU Yan;BAI Gui-qin;CHENG Jun;WU Shun-hua;WANG Lin;YAN Fu-ming;ZHANG Ling-xia;CUI Yu-fang
LIU Yan;BAI Gui-qin;CHENG Jun;WU Shun-hua;WANG Lin;YAN Fu-ming;ZHANG Ling-xia;CUI Yu-fang
..............page:738-740